Romanian Competition Authority Launches Inquiry into Retail Market for Pharmaceutical Products
On 27 September 2022, the Romanian competition authority announced the start of a sectoral inquiry into the retail market for pharmaceutical products.
The authority perceives a risk of diminished access to medicines at retail level, caused by inadequate levels of supply to pharmacies. As part of the inquiry, the authority will analyse both the structural features of the retail supply chain and the sectoral regulations impacting competition at retail level of the market.
In addition to the information and documents which may be requested by the authority within its discretion, interested parties may voluntarily submit their comments and proposals. Following the investigation, the authority will publish policy recommendations to remedy the competitive conditions.
Over the past decade, national competition authorities in several European countries, including Romania, have conducted sector inquiries into the supply and distribution of pharmaceuticals (for an overview, see, Van Bael & Bellis Life Sciences News and Insights, 16 June 2021).